Donati D, Di Liddo M, Zavatta M, Manfrini M, Bacci G, Picci P, Capanna R, Mercuri M
First University Orthopaedic Clinic, Rizzoli Orthopaedic Institute, Bologna, Italy.
Clin Orthop Relat Res. 2000 Aug(377):186-94. doi: 10.1097/00003086-200008000-00025.
From 1986 to 1994, 112 bone allograft reconstructions were performed in patients with high-grade osteosarcoma in whom neoadjuvant chemotherapy was administered. The allograft reconstruction was used in arthrodesis in 44 cases (41 knees, three ankles), as an intercalary graft in 39 (28 femurs, 11 tibias), as an osteoarticular graft in 22 (three proximal and/or distal humeri, six distal femurs, 13 proximal tibias), and as an allograft and prosthesis composite in seven (two proximal humeri, one proximal femurs, four proximal tibias). In 20 patients an autologous vascularized fibula was used to augment the allograft. Functional results were excellent or good in 74% of the patients after the primary surgery, and in 83% of the patients after secondary surgery. Complications include delayed union (49%) and fracture (27%), although there were no cases of deep infection. The incidence of delayed union, but not infection or fracture, was increased by the use of chemotherapy.
1986年至1994年期间,对接受新辅助化疗的高级别骨肉瘤患者进行了112例同种异体骨移植重建手术。同种异体骨移植重建用于关节固定术44例(41个膝关节,3个踝关节),作为节段性移植39例(28个股骨,11个胫骨),作为骨关节移植22例(3个近端和/或远端肱骨,6个远端股骨,13个近端胫骨),作为同种异体骨与假体复合物7例(2个近端肱骨,1个近端股骨,4个近端胫骨)。20例患者使用自体带血管腓骨增强同种异体骨。初次手术后74%的患者功能结果为优或良,二次手术后83%的患者功能结果为优或良。并发症包括骨愈合延迟(49%)和骨折(27%),但无深部感染病例。化疗会增加骨愈合延迟的发生率,但不会增加感染或骨折的发生率。